TCH (chemotherapy)

TCH
SpecialtyOncology

TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. TCHP is a variation that adds pertuzumab.[1]

References

  1. ↑ Van Belle, Hannah; Hurvitz, Sara A.; Gilbar, Peter J.; Wildiers, Hans (December 2021). "Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer". Breast Cancer Research and Treatment. 190 (3): 357–372. doi:10.1007/s10549-021-06387-1. ISSN 1573-7217. PMID 34533681.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.